BioCentury
ARTICLE | Clinical News

Angeliq oral once-daily estradiol and drospirenone regulatory update

October 21, 2002 7:00 AM UTC

SCH subsidiary Berlex Laboratories (Montville, N.J.) received a non-approvable letter from the FDA for Angeliq HRT therapy to treat menopausal symptoms. Earlier this month, SCH received a non-approvab...